Gene Therapy webinar series: Episode 7 – Health technology assessment (HTA) of genetic therapies

6 June 2024

Click here to register!

…TIMESLOT: Thursday 6 June 2024, 16:00 – 17:00 CEST

…THEME: Health technology assessment (HTA) of genetic therapies

…PRESENTERS: Prof. Oriana Ciani (SDA Bocconi School of Management)

Oriana Ciani is an Associate Professor of Practice in the Public Management and Policy, Health Economics, and HTA (Health Technology Assessment) Area at SDA Bocconi School of Management.

Her collaboration with SDA began in 2010. She coordinates the Epidemiology and Public Health module in the “Master of International Health Care Management, Economics and Politics” (MIHMEP) and teaches in numerous training courses for healthcare professionals on health economics and economic evaluation of healthcare interventions.

Her research interests focus on the use of Health Technology Assessment (HTA) in healthcare decision-making processes, methodological aspects of health technology assessments, particularly in the field of medical devices and digital technologies, evidence synthesis to inform policy choices. Oriana earned her PhD from the University of Exeter Medical School (UK) with a thesis on the validation of surrogate outcomes, which remains one of her main areas of interest.

She has participated in numerous national and international research projects, involving various partners, such as MedTecHTA (FP7 no. 305694), Mapping NCD (FP7 no. 602536), and COMED (H2020 no.779306). Since 2023, she has been the coordinator of the three-year HORIZON Europe project HI-PRIX (no. 101095593), focusing on innovative pricing and payment schemes for healthcare technologies.

In 2020, Oriana was a Fulbright Research Scholar at the Yale School of Medicine and the Yale School of Public Health. She serves as an Associate Editor of Value in Health and is the author of numerous internationally recognized publications. Her study published in the International Journal of Health Technology Assessment (2015) on HTA systems for medical devices received the Egon Jonsson Award in 2016. For her research activities, she has received other awards, including the Bocconi Research Award (2023), the Exeter Impact Award (2013), the Best Student Podium Presentation Award at the ISPOR Conference in Dublin (2013), and the young researchers award from AIES (2010).

Oriana holds a bachelor’s and master’s degree in Biomedical Engineering from the Polytechnic University of Milan and a Master’s in Healthcare Management from SDA Bocconi.

Fore more information on the full Gene Therapy webinar series click here!

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern